Literature DB >> 8595932

Blood polymorphonuclear leukocyte migratory activities during rheumatoid arthritis.

G Egger1, F Aglas, F Rainer.   

Abstract

Blood polymorphonuclear leukocyte (PMN) migratory activity was investigated in adult rheumatoid arthritis (RA) patients and in healthy control subjects using fresh whole blood in a novel membrane filter assay. The PMNs migrated under FMLP stimulation and under blank control conditions (spontaneous migration). Essential evaluation criteria were the percentage of PMNs that migrated from the entire blood sample into the filters (TMI) and the penetration depth of the migrating cell bulk into the filters (DC). PMNs from healthy subjects penetrate deeper under FMLP stimulation than under blank control conditions. Migration depends on age and sex: the TMI decreases, while the DC and the reactivity towards FMLP increase with age. FMLP triggers a stronger DC reaction in females than in males. Compared with healthy subjects, patients with RA develop an increased PMN reaction, whereas FMLP inhibits migration in comparison with the blank controls. There is no correlation between disease activity estimated by joint functions and PMN migratory activity, while there are strong correlations between disease activity and the classical RA laboratory parameters WBC, platelets, BSR, CRP, hemoglobin and rheumatoid factor. PMNs therefore probably do not play a major role in joint injury. Gold therapy inhibits DC reactivity. PMN migration in RA differs markedly from the reactions in juvenile rheumatoid arthritis, where high disease activity is associated with high PMN migratory activity, and the correlations between classical laboratory parameters and disease activity follow other patterns than in RA.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8595932     DOI: 10.1007/bf01534569

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  23 in total

1.  Cytokines and soluble interleukin 2 receptors in rheumatoid arthritis.

Authors:  R E Wolf; W G Brelsford; V C Hall; S B Adams
Journal:  J Rheumatol       Date:  1992-04       Impact factor: 4.666

2.  Therapeutic criteria in rheumatoid arthritis.

Authors:  O STEINBROCKER; C H TRAEGER; R C BATTERMAN
Journal:  J Am Med Assoc       Date:  1949-06-25

3.  Gold treatment of rheumatoid arthritis decreases synovial expression of the endothelial leukocyte adhesion receptor ELAM-1.

Authors:  M M Corkill; B W Kirkham; D O Haskard; C Barbatis; T Gibson; G S Panayi
Journal:  J Rheumatol       Date:  1991-10       Impact factor: 4.666

4.  Severe, unusual, and recurrent infections in rheumatoid arthritis.

Authors:  E C Huskisson; F D Hart
Journal:  Ann Rheum Dis       Date:  1972-03       Impact factor: 19.103

5.  Infection in rheumatoid arthritis.

Authors:  J Baum
Journal:  Arthritis Rheum       Date:  1971 Jan-Feb

6.  Oxidative modification of low density lipoproteins by human polymorphonuclear leukocytes.

Authors:  E Wieland; A Brandes; V W Armstrong; M Oellerich
Journal:  Eur J Clin Chem Clin Biochem       Date:  1993-11

7.  Superoxide-dependent stimulation of leukocyte adhesion by oxidatively modified LDL in vivo.

Authors:  H A Lehr; M Becker; S L Marklund; C Hübner; K E Arfors; A Kohlschütter; K Messmer
Journal:  Arterioscler Thromb       Date:  1992-07

8.  Reliability of grip strength, walking time and button test performed according to a standard protocol.

Authors:  T Pincus; R H Brooks; L F Callahan
Journal:  J Rheumatol       Date:  1991-07       Impact factor: 4.666

9.  Auranofin inactivates phosphofructokinase in human neutrophils, leading to depletion of intracellular ATP and inhibition of superoxide generation and locomotion.

Authors:  R Anderson; C E Van Rensburg; G K Jooné; A Lessing
Journal:  Mol Pharmacol       Date:  1991-09       Impact factor: 4.436

Review 10.  Evaluation of the role of cytokines in autoimmune disease: the importance of TNF alpha in rheumatoid arthritis.

Authors:  M Feldmann; F M Brennan; R O Williams; A P Cope; D L Gibbons; P D Katsikis; R N Maini
Journal:  Prog Growth Factor Res       Date:  1992
View more
  3 in total

1.  Blood polymorphonuclear leukocyte activation in atherosclerosis: effects of aspirin.

Authors:  G Egger; A Burda; A Obernosterer; H Mitterhammer; G Kager; G Jürgens; H P Hofer; J S Fabjan; E Pilger
Journal:  Inflammation       Date:  2001-04       Impact factor: 4.092

2.  Peripheral blood neutrophil leukotriene B4 release and migration in rheumatoid arthritis.

Authors:  H Kankaanranta; E Moilanen; T Tuomiranta; M Korpela; U Yli-Kerttula; H Isomäki; H Vapaatalo
Journal:  Inflammation       Date:  1996-10       Impact factor: 4.092

3.  Blood polymorphonuclear leukocyte migration as a predictive marker for infections in severe trauma: comparison with various inflammation parameters.

Authors:  Gerd Egger; Reingard Aigner; Andreas Glasner; Herwig P Hofer; Heike Mitterhammer; Sieglinde Zelzer
Journal:  Intensive Care Med       Date:  2004-01-16       Impact factor: 17.440

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.